Your browser doesn't support javascript.
loading
Corrigendum to "AC220 and AraC cause differential inhibitory dynamics in patient-derived M5-AML with FLT3-ITD and, thus, ultimately distinct therapeutic outcomes" [Experimental Hematology 2017;45:36-44].
An, Xiaoyu; Liu, Jinping; Wang, Na; Wang, Di; Huang, Liang; Zhang, Likun; Cai, Jie; Wery, Jean-Pierre; Zhou, Demin; Zhou, Jianfeng; Li, Qi-Xiang.
Afiliação
  • An X; Crown Bioscience, Inc., Santa Clara, CA, USA.
  • Liu J; Crown Bioscience, Inc., Santa Clara, CA, USA.
  • Wang N; Cancer Biology Research Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
  • Wang D; Cancer Biology Research Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
  • Huang L; Cancer Biology Research Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
  • Zhang L; Crown Bioscience, Inc., Santa Clara, CA, USA.
  • Cai J; Crown Bioscience, Inc., Santa Clara, CA, USA.
  • Wery JP; Crown Bioscience, Inc., Santa Clara, CA, USA.
  • Zhou D; State Key Laboratory of Natural and Biomimetic Drugs, Peking University, Beijing, China.
  • Zhou J; Cancer Biology Research Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
  • Li QX; Crown Bioscience, Inc., Santa Clara, CA, USA; State Key Laboratory of Natural and Biomimetic Drugs, Peking University, Beijing, China.
Exp Hematol ; 93: 85, 2021 Jan.
Article em En | MEDLINE | ID: mdl-33189657

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article